| scholarly article | Q13442814 |
| P50 | author | Susumu Katsuma | Q91794056 |
| P2093 | author name string | Akira Hirasawa | |
| Gozoh Tsujimoto | |||
| Yoshinao Ruike | |||
| Mai Kimura | |||
| Takeaki Yano | |||
| P2860 | cites work | Signalling mechanisms in sphingosine 1-phosphate-promoted mesangial cell proliferation | Q44251129 |
| Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-beta-induced cell responses | Q44932630 | ||
| Regulation of connective tissue growth factor (CTGF/CCN2) gene transcription and mRNA stability in smooth muscle cells. Involvement of RhoA GTPase and p38 MAP kinase and sensitivity to actin dynamics | Q45160526 | ||
| Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins | Q28144427 | ||
| International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature | Q28201589 | ||
| Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells | Q28369901 | ||
| Selective regulation of Galpha(q/11) by an RGS domain in the G protein-coupled receptor kinase, GRK2 | Q28611497 | ||
| Regulation of tyrosine kinase cascades by G-protein-coupled receptors. | Q33597362 | ||
| Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis | Q34050059 | ||
| Transforming growth factor-β and connective tissue growth factor: key cytokines in scleroderma pathogenesis | Q34431029 | ||
| Transcriptional profiling of gene expression patterns during sphingosine 1-phosphate-induced mesangial cell proliferation | Q38359200 | ||
| Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform | Q39740344 | ||
| Expression profiling of baculovirus genes in permissive and nonpermissive cell lines. | Q40515409 | ||
| The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts | Q41766529 | ||
| CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells | Q42437301 | ||
| Induction of connective tissue growth factor by activation of heptahelical receptors. Modulation by Rho proteins and the actin cytoskeleton | Q42493036 | ||
| CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling | Q42498294 | ||
| CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. | Q42526004 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | connective tissue | Q25615 |
| mesangial cell | Q3331086 | ||
| P304 | page(s) | 2576-2582 | |
| P577 | publication date | 2005-04-08 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Transcriptional regulation of connective tissue growth factor by sphingosine 1-phosphate in rat cultured mesangial cells | |
| P478 | volume | 579 |
| Q42963879 | Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P signaling pathway |
| Q34399505 | Berberine reduces fibronectin expression by suppressing the S1P-S1P2 receptor pathway in experimental diabetic nephropathy models |
| Q42024430 | Bombyx mori nucleopolyhedrovirus ORF34 is required for efficient transcription of late and very late genes |
| Q34679061 | Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells |
| Q48082716 | Glucocorticoid-induced alternative promoter usage for a novel 5' variant of granzyme A. |
| Q30438371 | Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2 |
| Q35970142 | Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells. |
| Q35027055 | Nephrokeli, a Chinese herbal formula, may improve IgA nephropathy through regulation of the sphingosine-1-phosphate pathway |
| Q47642258 | Plasma Connective Tissue Growth Factor (CTGF/CCN2) Levels Predict Myocardial Infarction in the Veterans Affairs Diabetes Trial (VADT) Cohort |
| Q36912563 | Rho/ROCK pathway as a molecular target for modulation of intestinal radiation-induced toxicity. |
| Q36729090 | Role of CCN2/CTGF/Hcs24 in bone growth |
| Q37111035 | SOX9 directly Regulates CTGF/CCN2 Transcription in Growth Plate Chondrocytes and in Nucleus Pulposus Cells of Intervertebral Disc. |
| Q38034353 | Sphingosine-1-phosphate: A Janus-faced mediator of fibrotic diseases |
| Q34678040 | Sphingosine‐1‐phosphate antibodies as potential agents in the treatment of cancer and age‐related macular degeneration |
| Q41265082 | Systems Chemo-Biology and Transcriptomic Meta-Analysis Reveal the Molecular Roles of Bioactive Lipids in Cardiomyocyte Differentiation |
| Q38116071 | Targeting the Sphingosine Kinase/Sphingosine 1‐Phosphate Pathway to Treat Chronic Inflammatory Kidney Diseases |
| Q24653621 | The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts |
Search more.